Rudolf Urbanics, MD, PhD
Head of research (in vivo)
Rudolf Urbanics, MD, PhD, Head of the in vivo laboratory SeroScience Ltd., an immunotoxicity CRO, since 2008 in Budapest, Hungary. He obtained MD diploma at Semmelweis Medical School, Budapest, Hungary and the PhD degree at the Academy of Sciences. He had teaching and research activity at the parent university and held in between various research/collaboration positions at MaxPlanck Institute of Systemphysiology, Dortmund, Germany, at University of Pennsylvania, Philadelphia, at Pennsylvania Muscle Institute, in the Knoll AG, Central Nervous System Research Department, working in the field of CNS regulation of blood flow/metabolism, ischemic/hypoxic disorders, stroke and chronic neurodegenerative disease models. He was the Deputy R&D Director and Head of CNS Pharmacology at Biorex R&D Co., worked at IVAX/Drug Research Institute Budapest, as Scientific Adviser, Leading researcher in Safety and CNS Pharmacology. Currently, he is working with in vivo models of nano drug – nano carrier induced, complement activation related pseudoallergic reactions (CARPA), clarifying their immune-toxicological and safety hazards, working on prediction possibilities and developing methods for safe application of nanomedicines.
László Dézsi, PhD
Gergely Tibor Kozma, PhD
Head of research (in vitro)
Gergely Tibor Kozma, MSc, PhD, immunologist, Head of the in vitro laboratory of SeroScience Ltd. He received his MSc degree in bioengineering at Technical University Budapest, Faculty of Chemical Technology and Biotechnology; thereafter he obtained PhD in immunology and molecular biology at Semmelweis University. He was working at Semmelweis University and at several companies as a researcher studying mainly the immunological mechanisms of allergy and nano-drug induced hypersensitivity. He spent one and half a year in Rome as a postdoctoral researcher sponsored by the Marie Curie Research Training Network to investigate the antigen presenting processes of dendritic cells. Besides research he was also involved at assay developments in the field of monoclonal antibody production, ELISAs and protein engineering in E. coli. He is also a specialist of immune cells phenotyping by flow cytometry. His current field of research is the immunological study of nano-drug induced hypersensitivity reactions including mainly the complement activation related processes and immunogenicity. He has co-authored 20 original papers, with more than 700 citations.
Researcher, PhD student
Tamás Mészáros, MSc, research fellow at SeroScience Ltd., Budapest, Hungary since 2009. He received his MSc degree as an immunologist from Eötvös Lóránd University in 2009, Budapest, Hungary. He is currently pursuing his PhD degree at Semmelweis University, Budapest, Hungary. His has been working on CRO projects, in vitro research and development. His current field of research is the immunological study of nano-drug induced hypersensitivity reactions including mainly the complement activation related processes and immunogenicity. His special skills include in vitro ELISA assays and techniques.